LivaNova: Excellent Performer, But Too Expensive In 2026 (Rating Downgrade)
Source: SeekingAlpha
2026-02-27 04:55:13 ET
In this article, I'll provide an update on LivaNova PLC ( LIVN ), which has been part of my portfolio since mid-2025, and has seen a superb rate of outperformance relative to the market average, or [[SPY]]....
Read the full article on Seeking Alpha
For further details see:
LivaNova: Excellent Performer, But Too Expensive In 2026 (Rating Downgrade)
LivaNova PLC
NASDAQ: LIVN
LIVN Trading
-4.54% G/L:
$61.435 Last:
242,352 Volume:
$62.89 Open:
LIVN Latest News
LIVN Stock Data
$3,643,826,817
54,059,472
0.04%
98
N/A
Medical Equipment & Supplies
Healthcare
GB
London
